Abstract:Abstract Background The discordance between steady-state levels of mRNAs and protein has been attributed to posttranscriptional control mechanisms affecting mRNA stability and translation. Traditional methods of genome wide microarray analysis, profiling steady-state levels of mRNA, may miss important mRNA targets owing to significant posttranscriptional gene regulation by RNA binding proteins (RBPs). Methods The ribonomic approach, utilizing RNA immunoprecipitation hybridized to microarray (RIP-Chip), provides global identification of putative endogenous mRNA targets of different RBPs. HuR is an RBP that binds to the AU-rich elements (ARE) of labile mRNAs, such as proto-oncogenes, facilitating their translation into protein. HuR has been shown to play a role in cancer progression and elevated levels of cytoplasmic HuR directly correlate with increased invasiveness and poor prognosis for many cancers, including those of the breast. HuR has been described to control genes in several of the acquired capabilities of cancer and has been hypothesized to be a tumor-maintenance gene, allowing for cancers to proliferate once they are established. Results We used HuR RIP-Chip as a comprehensive and systematic method to survey breast cancer target genes in both MCF-7 (estrogen receptor positive, ER+) and MDA-MB-231 (estrogen receptor negative, ER-) breast cancer cell lines. We identified unique subsets of HuR-associated mRNAs found individually or in both cell types. Two novel HuR targets, CD9 and CALM2 mRNAs, were identified and validated by quantitative RT-PCR and biotin pull-down analysis. Conclusion This is the first report of a side-by-side genome-wide comparison of HuR-associated targets in wild type ER+ and ER- breast cancer. We found distinct, differentially expressed subsets of cancer related genes in ER+ and ER- breast cancer cell lines, and noted that the differential regulation of two cancer-related genes by HuR was contingent upon the cellular environment.

Cancer cell growth suppression by a 62nt AU-rich RNA from C/EBPβ 3'UTR through competitive binding with HuR.

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Tumor Suppression by Rna from C/Ebp Beta 3 ' Utr Through the Inhibition of Protein Kinase C Epsilon Activity

Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis

The RNA-binding protein HuR in human cancer: A friend or foe?

The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer

The Role of RNA-Binding Protein HuR in Lung Cancer by RNA Sequencing Analysis

RAB5C, a New Mrna Binding Target of HuR, Regulates Breast Cancer Cell Proliferation

Small Molecules Targeting the RNA-Binding Protein HuR Inhibit Tumor Growth in Xenografts

An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells

Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis

HuR, a Key Post-Transcriptional Regulator, and Its Implication in Progression of Breast Cancer.

Targeting the RNA-binding protein HuR in cancer.

Sequences Near Both Termini of the C/EBPbeta Mrna 3' Untranslated Region Are Important for Its Tumor Suppression Activity.

Molecular Mechanism of Tumor Suppression Activity of C/Ebp Beta Mrna 3 ' Utr: Simultaneous Deletion of 3 Short Sequences in the 3 ' Utr Reduces Its Tumor Suppression Activity

RNA-binding Protein HuR Regulates Hsa-Let-7c Expression by Its RNA Recognition Motif.

The Ccr2 3 ' Utr Functions As A Competing Endogenous Rna to Inhibit Breast Cancer Metastasis

RNA represses p 53 translation by competing with HuR

A transcribed ultraconserved noncoding RNA, uc.285+, promotes colorectal cancer proliferation through dual targeting of CDC42 by directly binding mRNA and protein

Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis

Circular RNA circ0104103 inhibits colorectal cancer progression through interactions with HuR and miR‐373‐5p